Journal of the Pancreas is believed to publish the most validated review articles on Cystic fibrosis. With the support of eminent editorial board and efficient reviewers entire peer-reviewing process is done through editorial manager system which assures the publication of high quality articles related to Cystic fibrosis.
Cystic fibrosis (CF) is an autosomal recessive genetic disorder that affects the lungs, pancreas, liver, and intestine. Its main characteristic is disrupted transport of chloride and sodium across an epithelium, which leads to thick, viscous secretions. It is also known as mucoviscidosis. Abnormal breathing is the most serious symptom which results from frequent lung infections. Cystic fibrosis is caused by a frameshift mutation in the gene for the protein cystic fibrosis transmembrane conductance regulator. (CFTR). The name cystic fibrosis was given because there is a cyst formation in the Pancreas. The thick mucus secretion occurring due to cystic fibrosis block the way of digestive and endocrine enzymes of pancreas, causing a complete damage to pancreas.
OMICS Group, the leading online open access publisher systematically maintains more than 700+ peer-reviewed journals, Journal of the Pancreas being one among them are supported by very efficient editorial board and have more than 3 millionâs reader database. The other wing of OMICS International, OMICS Group conferences, successfully organizes around 3000+ International Scientific Conferences annually on emerging research topics in the fields of medical, clinical, engineering and life sciences.
Last date updated on June, 2014